A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
Authors:
- Gabriela GremelGGGabriela Gremel
- Dijana DjureinovicDDDijana Djureinovic
- Marjut NiinivirtaMNMarjut Niinivirta
- Alexander LairdALAlexander Laird
- Oscar LjungqvistOLOscar Ljungqvist
- Henrik JohannessonHJHenrik Johannesson
- Julia BergmanJBJulia Bergman
- Per-Henrik EdqvistPEPer-Henrik Edqvist
- Sanjay NavaniSNSanjay Navani
- Naila KhanNKNaila Khan
- Tushar PatilTPTushar Patil
- Åsa SivertssonÅSÅsa Sivertsson
Open Access
- 4 January 2017
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 1-9
Abstract
There is an unmet clinical need for better prognostic and diagnostic tools for renal cell carcinoma (RCC). Human Protein Atlas data resources, including the transcriptomes and proteomes of normal and malignant human tissues, were searched for RCC-specific proteins and cubilin (CUBN) identified as a candidate. Patient tissue representing various cancer types was constructed into a tissue microarray (n = 940) and immunohistochemistry used to investigate the specificity of CUBN expression in RCC as compared to other cancers. Two independent RCC cohorts (n = 181; n = 114) were analyzed to further establish the sensitivity of CUBN as RCC-specific marker and to explore if the fraction of RCCs lacking CUBN expression could predict differences in patient survival. CUBN was identified as highly RCC-specific protein with 58% of all primary RCCs staining positive for CUBN using immunohistochemistry. In venous tumor thrombi and metastatic lesions, the frequency of CUBN expression was increasingly lost. Clear cell RCC (ccRCC) patients with CUBN positive tumors had a significantly better prognosis compared to patients with CUBN negative tumors, independent of T-stage, Fuhrman grade and nodal status (HR 0.382, CI 0.203–0.719, P = 0.003). CUBN expression is highly specific to RCC and loss of the protein is significantly and independently associated with poor prognosis. CUBN expression in ccRCC provides a promising positive prognostic indicator for patients with ccRCC. The high specificity of CUBN expression in RCC also suggests a role as a new diagnostic marker in clinical cancer differential diagnostics to confirm or rule out RCC.Keywords
Funding Information
- Swedish Cancer Society (2012/598)
- Knut och Alice Wallenbergs Stiftelse (2008.0143)
- Office of the Chief Scientist, Ministry of Health (ETM37)
- Chief Scientist Office (ETM37)
This publication has 24 references indexed in Scilit:
- Renal TumorsAmerican Journal of Surgical Pathology, 2013
- Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient OutcomePLOS ONE, 2013
- Value of PAX2 Immunostaining in Tumor DiagnosisAdvances in Anatomic Pathology, 2012
- Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein AtlasJournal of Visualized Experiments, 2012
- The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell CarcinomaPLOS ONE, 2011
- A Comprehensive Analysis of PAX8 Expression in Human Epithelial TumorsAmerican Journal of Surgical Pathology, 2011
- ZONAB Promotes Proliferation and Represses Differentiation of Proximal Tubule Epithelial CellsJournal of the American Society of Nephrology, 2010
- A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMAJournal of Urology, 2005
- Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cellsThe Journal of Physiology, 2003
- Characterization of an Epithelial ∼460-kDa Protein That Facilitates Endocytosis of Intrinsic Factor-Vitamin B12 and Binds Receptor-associated ProteinJournal of Biological Chemistry, 1997